In January-March 2025, PJSC Khimpharmzavod Chervona Zirka (Kharkiv) increased its net profit by 66% compared to the same period in 2024, to UAH 6.144 million.
According to the company’s disclosure to the National Securities and Stock Market Commission, its net sales revenue for the period increased by 27% to UAH 100.558 million.
Chervona Zirka is a Ukrainian manufacturer of medicines, therapeutic cosmetics, and dietary supplements.
According to the OpenDataBot system, the company’s net profit for 2024 amounted to UAH 24.063 million, which is 64% more than in 2023.
The ultimate beneficiary of the company is Elena Galkina.
